Affinity Health (Oak Brook)

Oak Brook, Illinois 60523-4655

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed